TITLE

MS, TM, AND DEPRESSION

PUB. DATE
November 2011
SOURCE
New Mobility;Nov2011, Vol. 22 Issue 218, p27
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article focuses on depression wherein according to Adam Kaplin, psychiatric consultant at John Hopkins Hospital, states that depression occurs at a rate as high as 50 percent for those with multiple sclerosis (MS) and ranks as a leading cause of death for those with transverse myelitis (TM).
ACCESSION #
67378372

 

Related Articles

  • Erratum to: Disentangling Multiple Sclerosis and depression: an adjusted depression screening score for patient-centered care. Gunzler, Douglas; Perzynski, Adam; Morris, Nathan; Bermel, Robert; Lewis, Steven; Miller, Deborah // Journal of Behavioral Medicine;Feb2016, Vol. 39 Issue 1, p178 

    A correction to the article "Disentangling Multiple Sclerosis and Depression: An Adjusted Depression Screening Score for Patient-Centered Care" published in the September 28, 2015 online issue is presented.

  • Depression and MS. Jablow, Martha M. // Inside MS;Fall93, Vol. 11 Issue 3, p18 

    Reports on the etiology and treatment for depression among multiple sclerosis (MS) patients. Physiological causes of depression in people with MS; Overlapping symptoms between depression and MS; Combination of drug therapy with counseling; Relationship-sensitivity of the treatment for...

  • The relation between objective and subjective impairment in cognitive function among multiple sclerosis patients — the role of depression. Maor, Y.; Olmer, L.; Mozes, B. // Multiple Sclerosis (13524585);Apr2001, Vol. 7 Issue 2, p131 

    Objective: To evaluate the relations between perceived cognitive function and objective cognitive deficit and to assess variables affecting perceived cognitive function among multiple sclerosis (MS) patients. Methods: A cross sectional study of patients with MS. All patients were interviewed and...

  • Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire. Benedict, RHB; Munschauer, F; Linn, R; Miller, C; Murphy, E; Foley, F; Jacobs, L // Multiple Sclerosis (13524585);Feb2003, Vol. 9 Issue 1, p95 

    Since there is a need for cost-effective screening techniques to identify neuropsychological impairment in multiple sclerosis (MS) patients, and because existing methods require cognitive testing with subsequent interpretation by a neuropsychologist, a brief self-report procedure was developed...

  • Fatigue in multiple sclerosis: relationship to depression, disability, and disease pattern. Kroencke, D.C.; Lynch, S.G.; Denney, D.R. // Multiple Sclerosis (13524585);Apr2000, Vol. 6 Issue 2, p131 

    In order to investigate the associations between fatigue and depression, disability, and disease subtype, 207 individuals with clinically definite Multiple Sclerosis (MS) were administered the Fatigue Severity Scale and the Zung Self-rating Depression Scale during a regular clinic appointment....

  • Fatigue in multiple sclerosis and its relationship to depression and neurologic disability. Bakshi, R.; Shaikh, Z.A.; Miletich, R.S.; Czarnecki, D.; Dmochowski, J.; Henschel, K.; Janardhan, V.; Dubey, N.; Kinkel, P.R. // Multiple Sclerosis (13524585);Jun2000, Vol. 6 Issue 3, p181 

    We studied multiple sclerosis fatigue (MSF) and its relationship to depression and disability. Seventy-one patients [50 relapsing-remitting, 21 secondary progressive] were grouped by Fatigue Severity Scale (FSS) into MS-fatigue (MSF) (FSS$$$5; n=46) or MS-nonfatigue (MSNF) (FSS$$$4; n=20)....

  • Depressive symptoms in a treated multiple sclerosis cohort. Patten, Scott B; Fridhandler, Shanika; Beck, Cynthia A; Metz, Luanne M // Multiple Sclerosis (13524585);Dec2003, Vol. 9 Issue 6, p616 

    Background: Recent side effect data from clinical trials of interferon beta in multiple sclerosis (MS) have failed to confirm that these medications are associated with an increased risk of depression. However, these studies have used highly selected samples and the results may not be...

  • Factors that contribute to quality of life outcomes prioritised by people with multiple sclerosis. Somerset, Maggie; Peters, Tim J.; Sharp, Deborah J.; Campbell, Rona // Quality of Life Research;Feb2003, Vol. 12 Issue 1, p21 

    The aim was to investigate factors associated with depression and social function, two outcomes identified as important by people with multiple sclerosis (MS) and to identify underlying dimensions of psycho-social well-being that may be useful as outcome measures. People with MS in eight...

  • Multiple sclerosis and depression: influence of interferon β therapy. Zephir, Hélène; De Seze, Jérôme; Stojkovic, Tanya; Delisse, Brigitte; Ferriby, Didier; Cabaret, Marilyn; Vermersch, Patrick // Multiple Sclerosis (13524585);Jun2003, Vol. 9 Issue 3, p284 

    Background and objectives: Depression is frequently part of the clinical picture of multiple sclerosis (MS). Major depression affects one in two patients with MS during the course of their lifetime. Our objectives were to determine first, whether interferon β-1a (IFN β-1a) treatment...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics